NCT05110196 2025-12-03
Study of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC.
Novartis
Phase 4 Completed
Novartis
Jemincare
Pfizer
Sirtex Medical
Pfizer
Celgene
Xoft, Inc.
AstraZeneca
Cytori Therapeutics
National Institutes of Health Clinical Center (CC)